Skip to main content

FDA

By Aline Noizet | 03:43 am | June 30, 2020
Mental health problems have been a rising issue globally over the past decade due to an ever more demanding society, in addition to the exponential increase in the use of social media, as reported by the American Psychological Association. Digital health connector, Aline Noizet, takes a closer look at some of the emerging tools available to those suffering with increased mental health challenges during COVID-19.
By Dave Muoio | 12:08 pm | June 26, 2020
The device monitors vitals from up to four feet away, and is designed for use in healthcare settings or at home.
By Dave Muoio | 04:15 pm | June 24, 2020
Also: TapestryHealth purchases its telehealth tech vendor; Tech professionals eyeing healthcare and pharma jobs with new interest after COVID-19.
By Dave Muoio | 06:39 pm | June 15, 2020
The long-awaited decision is the first regulatory authorization for Akili, and the first game-based therapeutic that the FDA has greenlit for any condition.
By Dave Muoio | 03:51 pm | June 03, 2020
Healthcare providers use a web interface to prescribe an initial dose "and BlueStar does the rest," according to Welldoc's chief medical officer.
By Dave Muoio | 04:19 pm | May 26, 2020
The digital respiratory health company says this deal and clearance now give it access to 90% of the U.S. asthma and COPD market.
By Dave Muoio | 12:40 pm | May 19, 2020
The consumer-facing digital platform for health testing was forced to pump the brakes on a similar offering roughly two months ago.
By Laura Lovett | 04:53 pm | May 14, 2020
Eko's ECG low ejection fraction tool will now be able to help clinicians spot cardiac complications associated with the novel coronavirus. 
By Laura Lovett | 05:03 pm | May 08, 2020
Users will now be able to collect a sample at home and send it to the lab in a sealed package.
By Laura Lovett | 03:00 pm | May 06, 2020
This news means that the Australian company will be able to expand to the United States.